Overview
Melanotan 2 (MT2) is a synthetic analogue of alpha-MSH, the hormone that drives skin pigmentation. It produces a deep tan with minimal sun exposure — which made it a grey-market phenomenon two decades ago and keeps it popular despite a genuinely concerning safety profile.
It also has pro-sexual effects (its cousin PT-141 was developed from it) and suppresses appetite in some users.
How It Works
MT2 activates melanocortin receptors, primarily MC1R in melanocytes, which ramps up melanin production — the pigment that darkens skin. It is non-selective, also hitting MC3R and MC4R, which explains the appetite suppression and sexual effects.
Tanning without sun, mostly
The peptide dramatically lowers the UV threshold needed to tan. Users still need some sun or UV exposure for full effect, but a fraction of their normal dose produces a deeper result — theoretically reducing total UV damage, though this has never been demonstrated in trials.
Key Benefits
Deep tan with minimal UV — the core effect, and it genuinely works.
Appetite suppression — a side effect some users leverage deliberately.
Libido and erectile effects — real enough that a derivative (PT-141/bremelanotide) was developed and approved for sexual dysfunction.
Photoprotection for the fair-skinned — the original research rationale, for people who burn instantly.
Side Effects & Considerations
Acute effects are common: nausea, facial flushing, spontaneous erections in men, and yawning. Longer-term, MT2 darkens moles and freckles and can create new pigmented lesions — the dermatological concern is obvious.
The melanoma question
Case reports of melanoma in MT2 users exist. Causation is unproven — users are often fair-skinned sun-seekers, the highest-risk group anyway — but stimulating melanocyte activity with an unregulated compound is not a risk to wave away. Any changing mole on MT2 deserves immediate dermatological evaluation. Not approved for human use anywhere; quality control on the grey market is poor.
Dosage protocols
| Protocol | Dosage | Frequency | Duration | Notes |
|---|---|---|---|---|
| Loading (anecdotal) | 250-500 mcg | Daily | 2-3 weeks | Start low (100-250 mcg) to assess nausea tolerance. Evening dosing sleeps through the side effects. |
| Maintenance | 500 mcg | 1-2 times weekly | As desired | Maintain with minimal UV exposure. |
Warnings
Not approved for human use. Darkens moles — monitor skin and see a dermatologist for any changes. Common nausea and flushing.